Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:09 AM ET 10-Q
Financial Results Shopify Inc. SHOP

Shopify Q3 2026 Results: Net Income $462M, Up 75.0% YoY

Shopify reported strong growth for the third quarter of 2026, with total revenue increasing to $3.74 billion compared to $2.84 billion in the prior year, driven largely by Merchant Solutions. Net income for the nine months ended September 30, 2026, rose significantly to $1.38 billion from $488 million in 2025, reflecting improved operational efficiency and higher gross profits.

Key figure
Net income $462M · +75.0% YoY
8:09 AM ET 8-K
Business Update Hamilton Lane INC HLNE

Hamilton Lane Business Update

Hamilton Lane reported its second quarter fiscal 2027 results and declared a quarterly dividend of $0.60 per share. The company highlighted its total assets under management and supervision reached approximately $1.1 trillion as of September 30, 2026.

8:09 AM ET 8-K
Financial Results Bowhead Specialty Holdings Inc. BOW

Bowhead Specialty Holdings Financial Results

Bowhead Specialty Holdings reported Q3 2026 financial results with gross written premiums increasing 10.8% to $256.4 million. The company achieved a net income of $12.9 million and an adjusted return on equity of 15.9%, driven by growth in its Baleen Specialty division and digital underwriting models.

Term
Q3 2026

“Our third quarter results reflect the continued execution of our strategy, with gross written premiums increasing almost 11%, adjusted net income growing 16%, and adjusted return on equity reaching 15.9% for the quarter. Our digital businesses grew to almost 9% of total gross written premiums, demonstrating that our complementary craft and digital underwriting models are working as intended and broadening our opportunities for disciplined premium growth across market cycles.”

Stephen Sills, Chief Executive Officer
8:09 AM ET 8-K
Financial Results Vital Farms, Inc. VITL

Vital Farms Financial Results

Vital Farms reported Q3 2026 net revenue of $182.2 million, an 8.4% year-over-year decrease but a 9.7% sequential improvement from the second quarter. The company reported a net loss of $6.5 million and updated its full-year 2026 revenue outlook to approximately $730 million while withdrawing its 2030 financial targets.

Term
Q3 2026

“Q3 represented a meaningful sequential improvement from Q2, consistent with our previously communicated expectation that Q2 would represent the trough in our financial performance. Net revenue and Adjusted EBITDA both improved sequentially, distribution expanded, we reached record dollar and volume share of the shell egg category, and we made progress reducing excess supply and lowering our cost structure.”

Russell Diez-Canseco, Vital Farms’ Executive Chairperson, President and CEO

“We achieved the distribution gains we expected, although some of that distribution came on shelf later than planned, and we are taking a more conservative view of its near-term velocity contribution. We are focused on building velocity across our expanded distribution base, adding distribution where it makes sense, bringing new households to the Vital Farms brand, and maintaining discipline across supply and costs.”

Russell Diez-Canseco, Vital Farms’ Executive Chairperson, President and CEO
8:09 AM ET 8-K
Financial Results First Watch Restaurant Group, Inc. FWRG

First Watch Restaurant Group Financial Results

First Watch Restaurant Group reported Q3 2026 financial results with total revenues increasing 10.7% to $349.9 million and net income rising to $4.8 million. The company opened 16 new system-wide restaurants during the quarter and raised its full-year 2026 Adjusted EBITDA outlook to approximately $136.0 million.

Term
Q3 2026

“Our third-quarter performance is another encouraging proof point for the strength of First Watch. We delivered on our top-line plan, grew same-restaurant sales against our toughest comparison of the year and increased total revenue by 10.7%, all while opening 16 system-wide restaurants across 11 states.”

Chris Tomasso, CEO and President of First Watch

“Our teams continue to execute at a high level, driving Adjusted EBITDA growth ahead of our expectations and giving us the confidence to raise our full-year 2026 Adjusted EBITDA outlook to the high end of our previous guidance range.”

Chris Tomasso, CEO and President of First Watch
8:09 AM ET 8-K
Financial Results Talen Energy Corp TLN

Talen Energy Financial Results

Talen Energy reported Q3 2026 GAAP net income of $138 million and Adjusted EBITDA of $669 million, driven by contributions from acquired assets and higher capacity revenues. The company introduced 2027 Adjusted EBITDA guidance of $2.5 billion to $2.85 billion and announced a $1.5 billion accelerated share repurchase program.

Term
Q3 2026

“Talen delivered $669 million of Adjusted EBITDA and $433 million of Adjusted Free Cash Flow in the third quarter. With nine months behind us, we are reaffirming the midpoint and are narrowing the range of our 2026 guidance. We are also introducing our 2027 guidance that reflects strong PJM fundamentals and a full year of contributions from our recently acquired assets.”

Mac McFarland, Talen Chief Executive Officer

“Share repurchases remain the benchmark against which we evaluate capital allocation. This quarter, we increased our share repurchase program to $3.0 billion, including a $1.5 billion accelerated share repurchase program. We have now repurchased more than one third of the shares outstanding at emergence.”

Terry Nutt, Talen President
8:09 AM ET 8-K
Financial Results Teva Pharmaceutical Industries Ltd TEVA

Teva Pharmaceutical Industries Financial Results

Teva Pharmaceutical Industries reported Q3 2026 revenues of $4.4 billion, a 2% decrease year-over-year due to competition for its generic Revlimid, offset by 33% growth in its innovative brand portfolio. The company raised its full-year 2026 revenue outlook for key brands AUSTEDO, AJOVY, and UZEDY following strong quarterly performance and gross margin expansion.

Term
Q3 2026

“Teva’s Pivot to Growth strategy is delivering strong results, as evidenced by the 33% growth across our key innovative brands and the substantial expansion of our non-GAAP gross profit margin to its highest level in a decade. We are strengthening our neuroscience leadership with the launch of WELTRUZA™ and the strategic addition of BXCL-501, while our biosimilars business is set to achieve its 2027 revenue goal a year ahead of schedule.”

Richard Francis, Teva's President and CEO
8:09 AM ET 8-K
Investor Presentation Carmax Inc KMX

Carmax Investor Presentation

CarMax hosted a virtual Strategic Update to detail its 'Shift into GEAR' growth strategy and multi-year financial framework through fiscal 2030. The company introduced long-term targets including a mid-single-digit used retail unit CAGR and a mid-teens adjusted EPS CAGR, focusing on improving customer experience and lowering operational costs.

8:09 AM ET 8-K
Financial Results Yum Brands Inc YUM

Yum Brands Financial Results

Yum! Brands reported Q3 2026 financial results, highlighted by a GAAP EPS of $5.92 which included a $1.7 billion pre-tax gain from the completed divestiture of the Pizza Hut brand. The company saw 7% unit growth at KFC and noted that Taco Bell U.S. has outpaced the QSR industry in same-store sales growth since the end of September.

Term
Q3 2026

“Yum! has entered its next chapter of growth, having completed the divestiture of Pizza Hut, with a sharper focus on our Raise the B.A.R. priorities. In support of those priorities, KFC delivered record Q3 global gross unit development and continues to scale its new global strategy reflecting the brand’s ambition of being the most modern chicken QSR.”

Chris Turner, CEO

“I’m also very pleased that, since the end of September, Taco Bell U.S. has been outpacing the QSR industry on same-store sales growth. Taco Bell will continue building on this momentum, with differentiated value and innovation that resonate across all consumer groups.”

Chris Turner, CEO
8:08 AM ET 8-K
Financial Results Henry Schein Inc HSIC

Henry Schein Financial Results

Henry Schein reported Q3 2026 financial results with total sales of $3.5 billion, representing 4.0% growth driven by strong U.S. dental merchandise volume. The company raised its full-year 2026 non-GAAP diluted EPS guidance to a range of $5.50 to $5.56, citing strong operating performance and net tariff refund benefits.

Term
Q3 2026

“We delivered another strong quarter that increases our confidence in the momentum we are building at Henry Schein. I am very pleased with the U.S. dental merchandise sales growth of 8.6% driven primarily by volume in a stable market and our 19% adjusted earnings per share growth.”

Fred Lowery, Chief Executive Officer of Henry Schein

“Our strategy is translating into stronger financial results. We are gaining share in key businesses, improving our portfolio mix, maintaining a disciplined approach to capital allocation, and realizing the benefits of our value creation initiatives.”

Fred Lowery, Chief Executive Officer of Henry Schein
8:08 AM ET 8-K
Financial Results Pfizer Inc PFE

Pfizer Financial Results

Pfizer reported Q3 2026 revenues of $16.6 billion, with 32% operational growth from launched and acquired products. The company raised its full-year 2026 revenue guidance to $62.0-$64.0 billion and appointed Cecile Guegan as its new Chief Financial Officer.

Term
Q3 2026

“Pfizer had another strong quarter with commercial momentum and disciplined execution while advancing our strategy for creating long-term shareholder value. Our obesity program continued to advance and recent milestones in oncology, immunology and vaccines further demonstrate the potential of our pipeline. With a robust slate of expected catalysts ahead, I believe we're well positioned to deliver meaningful new medicines for patients and lasting value in the years ahead.”

Dr. Albert Bourla, Chairman and CEO of Pfizer

“Our third-quarter results reflect strong commercial performance globally and continued operational discipline. This quarter, our non-COVID products delivered strong 7% operational revenue growth, and I’m particularly pleased with the 32% year-over-year operational revenue growth from our launched and acquired products. Today, we are raising our full-year 2026 Revenue and Adjusted diluted EPS guidance, reflecting our strong year-to-date performance and confidence in our business.”

Cecile Guegan, CFO and EVP of Pfizer
8:08 AM ET 8-K
Financial Results Marathon Petroleum Corp MPC

Marathon Petroleum Financial Results

Marathon Petroleum reported record third-quarter 2026 net income of $7.4 billion, driven by significantly higher market crack spreads and 100% crude capacity utilization. The company returned $3.3 billion to shareholders and announced a 10% increase in its quarterly dividend.

“Our value chain capabilities remain a defining advantage for us, capturing opportunities to enhance margins across dynamic market conditions. Strong planning, commercial, and operational execution generated significant cash flows, supporting high-return investments while delivering substantial returns to shareholders. MPLX’s durable growth and increasing cash flow to MPC delivers a differentiated value proposition.”

Maryann Mannen, Chairman, President and Chief Executive Officer
8:08 AM ET 8-K
Financial Results PJT Partners Inc. PJT

PJT Partners Financial Results

PJT Partners reported third quarter 2026 revenues of $385 million and record nine-month revenues of $1.29 billion. The company also announced an amendment to its $100 million revolving credit facility, extending the maturity date to November 2029. Despite a 14% year-over-year revenue decrease in the third quarter, the firm achieved record year-to-date pretax income and EPS.

Term
Q3 2026

“We continue to invest in our business to enhance our footprint, our capabilities, and our brand with the goal of better serving our clients and continuing to expand our market share. Our results continue to reflect this investment as we delivered record Revenues, record Pretax Income, and record EPS for the nine-month period. As before, we remain highly confident in our future growth prospects.”

Paul J. Taubman, Chairman and Chief Executive Officer
8:08 AM ET Form 4
Insider Buying Taiwan Semiconductor Manufacturing Co Ltd TSM

Taiwan Semiconductor Manufacturing Co VP Lipen Yuan Buys $71.5K of Stock

Lipen Yuan, VP, bought 1,000 shares of Taiwan Semiconductor Manufacturing Co Ltd at $71.49 a share, worth $71.5K in total on Nov 1, 2026. Shares held after the trade: 8,000 (+14.3%).

Value
$71.5K
Shares
1,000
Price
$71.49
Role
VP
Holding change
+14.3%
Trade date
Nov 1, 2026
8:08 AM ET 8-K
Financial Results Mplx LP MPLX

Mplx Financial Results

MPLX LP reported third-quarter 2026 net income of $1.2 billion and adjusted EBITDA of $1.9 billion, representing a 5.3% year-over-year increase. The company announced a 12.5% increase in its quarterly distribution to $1.2111 per unit and highlighted the start of operations at its Harmon Creek III processing plant.

Term
Q3 2026

“Our third-quarter results reflect strong execution and the continued progression of our integrated natural gas and NGL value chain growth strategy. The durability of our cash flows enabled us to increase our quarterly distribution by 12.5% for the third consecutive year.”

Maryann Mannen, MPLX chairman, president and chief executive officer

“MPLX is positioned to meet global demand for U.S. energy and deliver mid-single digit adjusted EBITDA growth as utilization increases across our system and key growth projects enter service.”

Maryann Mannen, MPLX chairman, president and chief executive officer
8:08 AM ET 8-K
Financial Results Amneal Pharmaceuticals, Inc. AMRX

Amneal Pharmaceuticals Financial Results

Amneal Pharmaceuticals reported Q3 2026 net revenue of $863 million, a 10% increase year-over-year, driven by strong growth in biosimilars and specialty products. Despite the revenue growth, the company posted a GAAP net loss of $22 million due to acquisition and integration costs related to Kashiv. Consequently, Amneal raised its full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS.

Term
Q3 2026

“Amneal delivered another quarter of strong, broad-based performance, enabling us to increase our 2026 guidance once more. As we prepare to enter 2027, our financial performance is accelerating driven by a number of key catalysts and new launches, including Women’s Health patches, biosimilars, injectables such as lanreotide, CREXONT®, and BREKIYA® autoinjector.”

Chirag and Chintu Patel, Co-Founders and Co-Chief Executive Officers
8:07 AM ET 10-Q
Financial Results Compass Pathways plc CMPS

Compass Pathways Q3 2026 Results: Net Loss of $9.83M, Loss Narrows

COMPASS Pathways plc is advancing its COMP360 psilocybin treatment, currently in Phase 3 for treatment-resistant depression (TRD) and Phase 2b/3 for PTSD. The company reported 141,710,353 shares outstanding as of October 28, 2026, and maintains a loan agreement with Hercules Capital for up to $100 million to support its clinical and commercialization efforts.

Key figure
Net loss $9.83M
8:07 AM ET 8-K
Financial Results Athene Holding Ltd. ATH-PA

Athene Holding Financial Results

Athene Holding Ltd. reported its third quarter 2026 financial results as part of the earnings presentation issued by its parent company, Apollo Global Management. The results were impacted by unrealized mark-to-market losses in the Retirement Services segment due to higher interest rates, though the company maintained strong spread-related earnings.

Term
3 months
8:07 AM ET 8-K
Financial Results Cinemark Holdings, Inc. CNK

Cinemark Holdings Financial Results

Cinemark Holdings reported record-breaking third quarter 2026 results, with total revenue increasing 23.5% year-over-year to $1.1 billion. Net income grew 146% to $123 million, driven by strong box office momentum and record premium large format performance. The company achieved its highest-ever third quarter Adjusted EBITDA of $268 million with significant margin expansion.

Term
Q3 2026

“Following our record-breaking second quarter, we once again delivered exceptional Q3 results with worldwide revenue and Adjusted EBITDA reaching third quarter highs, and Adjusted EBITDA margin expanding 460 basis points year-over-year.”

Sean Gamble, Cinemark’s President and CEO

“Looking ahead, we remain highly confident in our long-term growth prospects and value proposition, supported by favorable consumer trends and content dynamics, as well as the distinct advantages we derive from our high-quality circuit, healthy balance sheet and differentiated competitive position.”

Sean Gamble, Cinemark’s President and CEO
8:07 AM ET 8-K
Financial Results Apollo Global Management, Inc. APO

Apollo Global Management Financial Results

Apollo Global Management reported third quarter 2026 results, highlighted by record quarterly origination of $114 billion and total assets under management reaching approximately $1.07 trillion. The company also declared a quarterly cash dividend of $0.5625 per share payable on November 30, 2026.

Term
Q3 2026

“Our strong third quarter results reflect the flywheel of our model, which starts with originating increasing amounts of good assets. Origination reached a new high of $114 billion in the quarter, and over the last twelve months, activity exceeded $350 billion while our clients entrusted us with $270 billion of inflows. Behind record pipelines and tangible momentum across the business, our core earnings power is growing and poised for a robust close to 2026 with a strong setup for 2027. Our mission remains clear: we are continuing to build a better, faster, stronger Apollo that is well positioned to lead the next generation of financial services.”

Marc Rowan, Chairman and Chief Executive Officer
8:07 AM ET 8-K
Financial Results Xenia Hotels & Resorts, Inc. XHR

Xenia Hotels & Resorts Financial Results

Xenia Hotels & Resorts reported third quarter 2026 financial results, significantly exceeding expectations with a 12.5% increase in Same-Property RevPAR and a 26% increase in Adjusted EBITDAre. The company narrowed its net loss to $2.7 million compared to $13.7 million in the prior year period, driven by strong group and corporate transient demand and disciplined expense management.

Term
Q3 2026

“Our third quarter results significantly surpassed our expectations, as strong broad-based group and corporate transient demand coupled with an incremental increase in leisure demand from several large events drove substantial increases in Same-Property RevPAR, Same-Property Total RevPAR and Same-Property Hotel EBITDA compared to the same period last year.”

Marcel Verbaas, Chairman and Chief Executive Officer
8:06 AM ET 8-K
Loan & Debt Braemar Hotels & Resorts Inc. BHR

Braemar Hotels & Resorts $75M Debt Financing with Western Alliance Bank

Braemar Hotels & Resorts refinanced its mortgage loan for The Ritz-Carlton, Lake Tahoe with a new $75 million facility from Western Alliance Bank, consisting of a $60 million term loan and a $15 million earnout facility. The new loan features a floating interest rate of SOFR + 2.65% and extends the final maturity to October 2031, replacing an existing $43.4 million loan that was set to mature in January 2027.

Value
$75M
Counterparty
Western Alliance Bank
Term
Initial term through Oct 2029, final maturity Oct 2031
8:06 AM ET 10-Q
Financial Results Clarivate PLC CLVT

Clarivate Q3 2026 Results: Net Loss of $80.8M, Loss Widens

Clarivate PLC reported a decrease in total assets from $11,069.4 million at the end of 2025 to $10,368.3 million as of September 30, 2026. The company is currently executing a Value Creation Plan and has classified its Life Sciences & Healthcare business as held for sale, while maintaining a significant long-term debt position of $4,136.8 million.

Key figure
Net loss $80.8M
8:06 AM ET 8-K
Financial Results DuPont de Nemours, Inc. DD

DuPont de Nemours Financial Results

DuPont reported third quarter 2026 results with net sales of $1.9 billion, up 4% year-over-year, and organic sales growth of 5%. The company exceeded its quarterly guidance and raised its full-year 2026 outlook, driven by strong performance in Healthcare & Water Technologies and Diversified Industrials.

Term
Q3 2026

“We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance. Mid-single-digit organic growth, strong operating leverage and disciplined capital allocation drove significant adjusted EPS growth. Additionally, we delivered strong free cash flow performance, with 121% conversion, underscoring the quality of our earnings and effective execution.”

Lori Koch, DuPont Chief Executive Officer

“We are executing from a position of strength and remain focused on unlocking the full potential of our portfolio to deliver sustained long-term value creation.”

Lori Koch, DuPont Chief Executive Officer
8:06 AM ET 10-K
Financial Results Apple Inc. AAPL ▶ Call

Apple FY 2026 Results: Net Income $132B, Up 18.0% YoY

Apple Inc. reported a workforce of approximately 167,000 employees as of September 2026 and highlighted risks associated with emerging technologies like AI and machine learning. The company noted significant supply chain concentration in Asia and warned of new U.S. tariffs announced in early 2025 that could impact costs and product availability.

Key figure
Net income $132B · +18.0% YoY
8:05 AM ET 8-K
Financial Results Gartner Inc IT

Gartner Financial Results

Gartner reported Q3 2026 financial results with revenues of $1.5 billion and a significant increase in net income to $214 million. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted EPS following accelerated contract value growth.

Term
Q3 2026

“Contract Value growth accelerated again. Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow were ahead of expectations. We repurchased $1.7 billion of stock over the last four quarters, as our capital allocation continues to create value for our shareholders. In addition, we increased our full year Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow guidance.”

Gene Hall, Gartner’s Chairman and Chief Executive Officer
8:05 AM ET 8-K
Financial Results Clarivate PLC CLVT

Clarivate Financial Results

Clarivate reported third quarter 2026 results with total revenues of $567.9 million and a net loss of $80.8 million, impacted by a $62.2 million goodwill impairment charge related to the Life Sciences & Healthcare segment. The company completed the divestiture of its Life Sciences & Healthcare segment on October 6, 2026, and updated its full-year 2026 financial outlook to reflect the transaction.

“Third quarter results continued to improve across key metrics, including organic recurring revenue growth and the return to positive ACV growth in the Intellectual Property segment. We also achieved a major milestone with the early close of the Life Sciences & Healthcare segment divestiture, positioning us for enhanced value creation in our two market-leading segments, Academia & Government and Intellectual Property. The growing commercial traction and customer validation from our AI-led innovation within A&G and IP give us confidence in our ability to deliver on our commitments of accelerating sustained organic growth, expanding free cash flow and reducing leverage.”

Matti Shem Tov, Chief Executive Officer

“We are seeing the benefits of disciplined execution across the business, with improving growth trends, strong margins and continued free cash flow generation. Our focus remains on translating organic growth into sustainable earnings and free cash flow, while maintaining a disciplined approach to capital allocation. Looking ahead, we are well positioned to further strengthen our financial profile and enhance our financial flexibility.”

Michael Easton, Executive Vice President and Chief Financial Officer
8:05 AM ET 8-K
Financial Results Ideaya Biosciences, Inc. IDYA

Ideaya Biosciences Financial Results

IDEAYA Biosciences reported Q3 2026 financial results, highlighting the completion of its first NDA submission for darovasertib in metastatic uveal melanoma. The company maintains a strong balance sheet with $1.15 billion in cash and equivalents, providing a projected cash runway into 2030.

Term
Q3 2026

“We are encouraged by the continued momentum at IDEAYA during the third quarter, marked by the successful completion of our first NDA filing for darovasertib in metastatic uveal melanoma. We also provided multiple clinical data updates at ESMO on darovasertib to support its potential as a foundational therapy across the entire uveal melanoma treatment journey as well as updated data from IDE849, our DLL3 TOP1 ADC, in relapsed SCLC and NEC.”

Yujiro S. Hata, Chief Executive Officer of IDEAYA
6:06 AM ET 10-Q
Financial Results Nuveen Churchill Direct Lending Corp. NCDL ▶ Call

Nuveen Churchill Direct Lending Q3 2026 Results: Net Income $16M, Down 14.3% YoY

For the nine months ended September 30, 2026, Nuveen Churchill Direct Lending Corp. reported total investment income of $134.3 million and net investment income of $59.0 million. The company's Net Asset Value (NAV) per share decreased to $17.13 from $17.72 at the end of 2025, primarily driven by $30.8 million in total net realized and unrealized losses.

Key figure
Net income $16M · -14.3% YoY
6:05 AM ET 8-K
Bankruptcy & Restructuring Karyopharm Therapeutics Inc. KPTIQ

Karyopharm Therapeutics Bankruptcy & Restructuring

Karyopharm Therapeutics Inc. and its subsidiary filed voluntary petitions for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Southern District of Texas. The company entered into a Restructuring Support Agreement with 100% of its funded debt holders and Ayrmid Ltd., which will serve as a stalking horse bidder for a merger with the reorganized company. The company will continue operations as a debtor-in-possession while seeking a court-supervised sale or reorganization to maximize stakeholder value.

Counterparty
Ayrmid Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.